newsfilter
← Latest News
GlobeNewswire·

Phoenix Biotech Acquisition Corp. Announces Pricing of $155,000,000 Initial Public Offering

Oakland, CA, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXU) (the "Company"), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or si